Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, April 2013

Altmetric Badge

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 69 Mendeley
citeulike: 1 CiteULike

Summary Blogs Dimensions citations

So far, Dimensions has found 42 publications that cite this research output.

42

The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.

An LC–MS/MS Analytical Method for Quantifying Tepotinib in Human Liver Microsomes: Application to In Vitro and In Silico Metabolic Stability Estimation

Article in Separations (May 2023)

A Rapid and Sensitive UPLC-MS/MS Method for Quantifying Capmatinib in Human Liver Microsomes: Evaluation of Metabolic Stability by In Silico and In Vitro Analysis

Article in Separations (April 2023)

Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials

Article in Pharmaceutics (April 2022)